Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human Calreticulin/CALR Protein, N-His

Catalog #:   YHD75201 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P27797
Protein length: Glu18-Pro204
Overview

Catalog No.

YHD75201

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Glu18-Pro204

Predicted molecular weight

23.67 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P27797

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Calreticulin, ERp60, CRTC, Calregulin, grp60, HACBP, Endoplasmic reticulum resident protein 60, CALR, CRP55

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human Calreticulin/CALR
References

Studying Immunogenic Cell Death in Human Colorectal Cancer Organoids., PMID:40502372

Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade., PMID:40480656

A rare CALR exon 9 mutation p.E379Vfs*53 in AYA generation exhibits gain-of-function nature and can induce essential thrombocythemia; a case report., PMID:40474352

Enhancing antitumor immunity via ROS-ERS and pyroptosis-induced immunogenic cell death in multiple myeloma., PMID:40473272

Design, Synthesis, and Evaluation of Pyrazolopyridine Derivatives as Novel Calreticulin (CALR) Ligands That Inhibit Triple-Negative Breast Cancer (TNBC) via Inducing Calcium Overloading., PMID:40464282

Generation of a Synthetic Single Domain Antibody Library for Radiopharmaceutical Ligand Discovery., PMID:40463173

Patritumab deruxtecan induces immunogenic cell death., PMID:40458967

A novel calreticulin of Psoroptes ovis regulated keratinocyte function resulting in host skin barrier dysfunction: implications for involvement in the pathogenesis of psoroptic mange., PMID:40448127

An Endoplasmic Reticulum Stress-Specific Nanoinducer Selectively Evokes Type-II Immunogenic Cell Death for Pyroptotic Cancer Immunotherapy., PMID:40434207

Comparative Transcriptome Analysis Elucidates the Desiccation Stress Adaptation in Sargassum muticum., PMID:40428409

NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors., PMID:40420289

Targeting CALR reduces energy metabolism of esophageal cancer cells and inhibits tumor‑associated fibroblast infiltration., PMID:40417915

Intrinsic Disorder and Phase Separation Coordinate Exocytosis, Motility, and Chromatin Remodeling in the Human Acrosomal Proteome., PMID:40407495

Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms., PMID:40403318

Macrophages release neuraminidase and cleaved calreticulin for programmed cell removal., PMID:40397678

Partial mitochondrial involvement in the antiproliferative and immunostimulatory effects of PT-112., PMID:40386940

Immunomodulatory effects of intratumoral cowpea mosaic virus and calreticulin nanoparticles in canine tumors: early results., PMID:40386779

A fermented Mistletoe (Viscum album L.) extract elicits markers characteristic for immunogenic cell death driven by endoplasmic reticulum stress in vitro., PMID:40369535

BiP, GRP94, calreticulin and calnexin contribute to development of the notochord in medaka fish., PMID:40368802

Differential regulation of mTORC2 signalling by type I and type II calreticulin (CALR) driver mutations of myeloproliferative neoplasm., PMID:40355863

Discovery of Cu(II)-Dipyridophenazine Complex for Synergistic Cuproptosis/Chemodynamic Therapy via Disrupting the Tricarboxylic Acid (TCA) Cycle in Metastatic TNBC., PMID:40348584

Combined exposure to atrazine and phoxim exacerbated the alterations of enzyme activity and abnormal gene expression in earthworms (Eisenia fetida)., PMID:40345462

Echinococcus multilocularis Calreticulin Inhibits Lectin Pathway of Complement Activation by Directly Binding to Mannose-Binding Lectin., PMID:40333123

Engineered Bacterial Biohybrid-Mediated CD47-SIRPα Blockade and HSP90 Inhibition for Enhanced Immuno-Photothermal Therapy., PMID:40331355

AlphaFold2 SLiM screen for LC3-LIR interactions in autophagy., PMID:40320752

DNA methylation in primary myelofibrosis is partly associated with driver mutations and distinct from other myeloid malignancies., PMID:40319310

Vaccinomics-driven selection and validation of protective salivary antigens from the argasid tick Ornithodoros moubata., PMID:40306020

Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion., PMID:40305178

Effects of anlotinib hydrochloride on the expression of immunogenic cell death-related molecules in Cal27 tongue cancer cells., PMID:40299226

Doxycycline-Induced Apoptosis in Brucella suis S2-Infected HMC3 Cells via Calreticulin Suppression and Activation of the IRE1/Caspase-3 Signaling Pathway., PMID:40290405

Phagocytosis-Activating Nanocomplex Orchestrates Macrophage-Mediated Cancer Immunotherapy., PMID:40289887

The relationship between serum levels of GRP78, GRP94, calnexin, and calreticulin and prognosis in patients with lung cancer., PMID:40289385

Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors., PMID:40287947

Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis., PMID:40287867

A BioID-based approach uncovers the interactome of hexose-6-phosphate dehydrogenase in breast cancer cells and identifies anterior gradient protein 2 as an interacting partner., PMID:40281598

Synergistic Induction of Immunogenic Cell Death by Biomineralized Manganese and Bisphosphonates Enhances Anti-PD-L1 Therapy in Triple-Negative Breast Cancer., PMID:40276640

In vitro evaluation of the immunogenic potential of gramicidin S and its photocontrolled analogues., PMID:40270993

Thrombospondin-1 induces immunogenic cell death in human mucoepidermoid carcinoma MC-3 cells via the PERK/eIF2α signaling pathway: potential implications for tumor immunotherapy., PMID:40253314

Nanoarchitectured hyaluronic acid-decorated hierarchical drug-like assemblies as synergistic immune modulators against breast carcinoma., PMID:40250652

Functional characterization of calreticulin in the antiviral response of Litopenaeus vannamei against white spot syndrome virus., PMID:40250553

An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy., PMID:40247106

LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth., PMID:40217513

Smad7 is a negative regulator of immunogenic cell death in colorectal cancer., PMID:40213961

Regulation of immunogenic cell death and potential applications in cancer therapy., PMID:40207233

Preliminary In silico Analysis of Echinococcus granulosus Calreticulin for Enhanced Vaccine Design against Cystic Echinococcosis., PMID:40195705

PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer., PMID:40185333

Complete assignment of 1H and 13C NMR signals of monoglucosylated high-mannose type glycan attached to asparagine., PMID:40168794

A CXCR4-targeted immunomodulatory nanomedicine for photodynamic amplified immune checkpoint blockade therapy against breast cancer., PMID:40154764

Dual blockade of GSTK1 and CD47 improves macrophage-mediated phagocytosis on cancer cells., PMID:40147800

High Expression of Calreticulin Affected the Tumor Microenvironment and Correlated With Worse Prognosis in Patients With Triple-Negative Breast Cancer., PMID:40123257

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human Calreticulin/CALR Protein, N-His [YHD75201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only